Entest Group Inc

[Paulness]

That third party thing did smell, when it happened, and that is why maybe ENTB lost Ms. Tammy Reynolds CFO


On August 8, 2011, Ms. Tammy Reynolds, a Director and Chief Financial Officer of Entest BioMedical, Inc. (the "Company"), submitted her resignation notice to the Company, effective immediately, from all of her positions with the Company including Director. The resignation was not motivated by a disagreement with the Company on any matter relating to the Company's operations, policies or practices. The Company believes that the resignation of Ms. Reynolds will not adversely impact the Company's disclosure controls and procedures and its internal control over financial reporting. Entest utilizes external consulting to ensure compliance with SEC reporting regulations and proper and timely preparation of financial statements